Elicio Therapeutics, Inc. (ELTX) income statement
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.45−0.05 (-3.33%)
Close on Nov 20, 2026Market cap $38.11MP/E –Yield –
Elicio Therapeutics, Inc. financial ratios
See a number that looks wrong?